3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Polycystic Ovary Syndrome
10
Infertility
6
Ovarian Cysts
2
Leiomyoma
2
Uterine Anomalies
1
Salpingitis
1
Primary Ovarian Insufficiency
1
Pregnancy, Ectopic
1
Infertility, Female
1
Endometritis
1
Endometriosis
1
Interventions
relugolix
2
vilaprisan
1
cetrorelix
1
Triptorelin Pamoate
1
Transcranial Direct Current Stimulation
1
Sutures
1
Surgical Instruments
1
Rocuronium
1
Robotic Surgical Procedures
1
Radiotherapy
1
Radiation
1
Menotropins
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Indocyanine Green
1
Immunonutrition Diet
1
Hysterectomy
1
Gonadotropins
1
Gonadotropin-Releasing Hormone
1
Fluconazole
1
Endoscopes
1
Electrocoagulation
1
Danazol
1
Chorionic Gonadotropin
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Endometriosis
×
cetrorelix
×
Clear all
NCT04071574
2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2
Completed
200 enrolled